A Study for Patients With Acute Leukemia

NCT01214655 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Stopped Primary objective has been met in the absence of clinically meaningful remissions

Conditions

Acute Leukemia

Interventions

DRUG: LY2523355

Sponsor

Eli Lilly and Company